I stumbled upon this NYT article about oncologists trying immunotherapy as a last shot, even if there isn’t any clear evidence (eg biomarker) that it will work in a specific patient. The article is about prostate cancer, but with MSS TMB moderate/high responders, similar arguments can be made for CRC.
Has anyone discussed trying an immunotherapy “Hail Mary” with their oncologist? Do you know of someone that tried it?
https://www.google.com/amp/s/www.nytimes.com/2018/04/26/health/doctors-cancer-immunotherapy.amp.html